These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7046053)

  • 1. Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin.
    Honn KV; Cavanaugh P; Evens C; Taylor JD; Sloane BF
    Science; 1982 Aug; 217(4559):540-2. PubMed ID: 7046053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin, thromboxanes, and hematogenous metastasis.
    Honn KV; Sloane BF
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():313-8. PubMed ID: 6221609
    [No Abstract]   [Full Text] [Related]  

  • 3. Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles.
    Cavanaugh PG; Sloane BF; Bajkowski AS; Gasic GJ; Gasic TB; Honn KV
    Clin Exp Metastasis; 1983; 1(4):297-307. PubMed ID: 6400436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinases and proteinase inhibition by cytotoxic and antimetastatic drugs in transplantable solid metastasizing tumors in mice.
    Giraldi T; Sava G; Perissin L; Zorzet S
    Anticancer Res; 1985; 5(4):355-9. PubMed ID: 3898994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin B-like activity in viable tumor cells isolated from rodent tumors.
    Ryan RE; Crissman JD; Honn KV; Sloane BF
    Cancer Res; 1985 Aug; 45(8):3636-41. PubMed ID: 3893687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some further characteristics of endogenous proteinase inhibitors.
    Kopitar M; Brzin J; Drobnic-Kosŏrok M; Babnik J; Locnikar P; Turk V; Giraldi T; Sava G
    Acta Biol Med Ger; 1982; 41(1):75-82. PubMed ID: 7051704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prostacyclin on tumor cell-induced platelet aggregation.
    Menter DG; Onoda JM; Taylor JD; Honn KV
    Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures and functions of lysosomal thiol proteinases and their endogenous inhibitor.
    Katunuma N; Kominami E
    Curr Top Cell Regul; 1983; 22():71-101. PubMed ID: 6347528
    [No Abstract]   [Full Text] [Related]  

  • 9. A general framework of cysteine-proteinase mechanism deduced from studies on enzymes with structurally different analogous catalytic-site residues Asp-158 and -161 (papain and actinidin), Gly-196 (cathepsin B) and Asn-165 (cathepsin H). Kinetic studies up to pH 8 of the hydrolysis of N-alpha-benzyloxycarbonyl-L-arginyl-L-arginine 2-naphthylamide catalysed by cathepsin B and of L-arginine 2-naphthylamide catalysed by cathepsin H.
    Willenbrock F; Brocklehurst K
    Biochem J; 1985 Apr; 227(2):521-8. PubMed ID: 3890831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis.
    Ostrowski LE; Ahsan A; Suthar BP; Pagast P; Bain DL; Wong C; Patel A; Schultz RM
    Cancer Res; 1986 Aug; 46(8):4121-8. PubMed ID: 3089587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of lysosomal proteinase activities and their expression in rat cultured keratinocytes during differentiation.
    Tanabe H; Kumagai N; Tsukahara T; Ishiura S; Kominami E; Nishina H; Sugita H
    Biochim Biophys Acta; 1991 Sep; 1094(3):281-7. PubMed ID: 1911879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by prostacyclin of the tumor cell-induced platelet release reaction and platelet aggregation.
    Menter DG; Onoda JM; Moilanen D; Sloane BF; Taylor JD; Honn KV
    J Natl Cancer Inst; 1987 May; 78(5):961-9. PubMed ID: 3553692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autodegradation of lysosomal cysteine proteinases.
    Kominami E; Tsukahara T; Bando Y; Katunuma N
    Biochem Biophys Res Commun; 1987 Apr; 144(2):749-56. PubMed ID: 3555495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor proteinases in tumor cell-induced platelet aggregation.
    Pacchiarini L; Grignani G; Pagliarino M; Ricetti MM; Bottazzi B; Mantovani A; Ascari E
    Invasion Metastasis; 1986; 6(5):287-301. PubMed ID: 3536793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The malignant phenotype and cysteine proteinases.
    Sloane BF; Rozhin J; Krepela E; Ziegler G; Sameni M
    Biomed Biochim Acta; 1991; 50(4-6):549-54. PubMed ID: 1801721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and enzymatic properties of a cathepsin L-like proteinase with distinct substrate specificity from northern shrimp (Pandalus borealis).
    Aoki H; Ahsan MN; Watabe S
    J Comp Physiol B; 2004 Jan; 174(1):59-69. PubMed ID: 14574613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of cathepsin B- and L-like proteinases in silk gland histolysis during metamorphosis of Bombyx mori.
    Shiba H; Uchida D; Kobayashi H; Natori M
    Arch Biochem Biophys; 2001 Jun; 390(1):28-34. PubMed ID: 11368511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulation of liver cysteine proteinases during macrophagal stimulation and depression].
    Korolenko TA; Svechnikova IG
    Vestn Ross Akad Med Nauk; 1998; (10):26-9. PubMed ID: 9846108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpura.
    Consonni R; Falanga A; Barbui T
    Br J Haematol; 1994 Jun; 87(2):321-4. PubMed ID: 7947274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a stable prostacyclin analogue on platelet activity and on host immunocompetence in mice.
    Costantini V; Fuschiotti P; Giampietri A; Allegrucci M; Agnelli G; Nenci GG; Fioretti MC
    Prostaglandins; 1990 Jun; 39(6):581-99. PubMed ID: 1695382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.